NO904689L - Fremgangsmaate til fremstilling av imidazo(4,5-b)-kinolinyloksyalkansyreamider. - Google Patents

Fremgangsmaate til fremstilling av imidazo(4,5-b)-kinolinyloksyalkansyreamider.

Info

Publication number: NO904689L
Authority: NO; Norway
Prior art keywords: cinolinyloxylkanic; acidamides; imidazo; procedure; preparation
Prior art date: 1989-11-01

Application number

NO90904689A

Other languages

English (en)

Other versions

NO904689D0 (no

NO175531B (no

NO175531C (no

Inventor

Nicholas Meanwell

Original Assignee

Bristol Myers Squibb Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-11-01

Filing date

1990-10-30

Publication date

1991-05-02

1990-10-30 Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co

1990-10-30 Publication of NO904689D0 publication Critical patent/NO904689D0/no

1991-05-02 Publication of NO904689L publication Critical patent/NO904689L/no

1994-07-18 Publication of NO175531B publication Critical patent/NO175531B/no

1994-10-26 Publication of NO175531C publication Critical patent/NO175531C/no

Links

150000001408 amides Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Hematology (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO904689A 1989-11-01 1990-10-30 Analogifremgangsmåte til fremstilling av terapeutisk aktive imidazo(4,5-b)-kinolinyloksyalkansyreamider NO175531C (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/430,228 US4943573A (en)	1989-11-01	1989-11-01	Imidazo[4,5-b]quinolinyloxyalkanoic acid amides with enhanced water solubility

Publications (4)

Publication Number	Publication Date
NO904689D0 NO904689D0 (no)	1990-10-30
NO904689L true NO904689L (no)	1991-05-02
NO175531B NO175531B (no)	1994-07-18
NO175531C NO175531C (no)	1994-10-26

Family

ID=23706624

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO904689A NO175531C (no)	1989-11-01	1990-10-30	Analogifremgangsmåte til fremstilling av terapeutisk aktive imidazo(4,5-b)-kinolinyloksyalkansyreamider

Country Status (20)

Country	Link
US (1)	US4943573A (no)
EP (1)	EP0426180A3 (no)
JP (1)	JPH03169880A (no)
KR (1)	KR910009705A (no)
CN (1)	CN1025999C (no)
AU (1)	AU639033B2 (no)
CA (1)	CA2027935A1 (no)
EG (1)	EG19372A (no)
FI (1)	FI92697C (no)
HU (1)	HU209305B (no)
IE (1)	IE61579B1 (no)
IL (1)	IL96167A (no)
MY (1)	MY105308A (no)
NO (1)	NO175531C (no)
NZ (1)	NZ235868A (no)
OA (1)	OA09323A (no)
PT (1)	PT95765A (no)
RU (1)	RU2041210C1 (no)
YU (1)	YU205590A (no)
ZA (1)	ZA908725B (no)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4943573A (en) *	1989-11-01	1990-07-24	Bristol-Myers Squibb Company	Imidazo[4,5-b]quinolinyloxyalkanoic acid amides with enhanced water solubility
US5149699A (en) *	1991-10-24	1992-09-22	American Home Products Corporation	Substituted pyridopyrimidines useful as antgiotensin II antagonists
PH31245A (en) *	1991-10-30	1998-06-18	Janssen Pharmaceutica Nv	1,3-Dihydro-2H-imidazoÄ4,5-BÜ-quinolin-2-one derivatives.
US5208237A (en) *	1992-04-03	1993-05-04	Bristol-Meyers Squibb Company	7-oxypropylsulfonamido-imidazo[4,5-b]quinolin-2-ones
US5196428A (en) *	1992-04-03	1993-03-23	Bristol-Myers Squibb Company	Imidazo[4,5-b]qinolinyl oxy alkyl ureas
US5552267A (en) *	1992-04-03	1996-09-03	The Trustees Of Columbia University In The City Of New York	Solution for prolonged organ preservation
US5348960A (en) *	1992-04-03	1994-09-20	Bristol-Myers Squibb Company	Imidazo[4,5-b]quinolinyl oxy alkyl tetrazolyl piperidine derivatives
US5158958A (en) *	1992-04-03	1992-10-27	Bristol-Myers Squibb Company	Imidazo[4,5-b]quinolinyl oxy alkyl sulfonyl piperidine derivatives
TW593317B (en)	1993-06-21	2004-06-21	Janssen Pharmaceutica Nv	Positive cardiac inotropic and lusitropic pyrroloquinolinone derivatives
US5672622A (en) *	1994-04-21	1997-09-30	Berlex Laboratories, Inc.	Treatment of multiple sclerosis
US6060501A (en) *	1994-06-02	2000-05-09	Schering Aktiengesellschaft	Combined treatment of multiple sclerosis
WO1996005202A1 (en) *	1994-08-17	1996-02-22	Nippon Hypox Laboratories Inc.	Imidazoquinoline derivative
US5798767A (en) *	1996-03-15	1998-08-25	Rendition, Inc.	Method and apparatus for performing color space conversion using blend logic
SE9902987D0 (sv) *	1999-08-24	1999-08-24	Astra Pharma Prod	Novel compounds
US20030186963A1 (en) *	2001-09-14	2003-10-02	Dorwald Florencio Zaragoza	Substituted piperidines
US7064135B2 (en)	2001-10-12	2006-06-20	Novo Nordisk Inc.	Substituted piperidines
WO2003031432A1 (en) *	2001-10-12	2003-04-17	Novo Nordisk A/S	Substituted piperidines and their use for the treatment of diseases related to the histamine h3 receptor
US7772188B2 (en)	2003-01-28	2010-08-10	Ironwood Pharmaceuticals, Inc.	Methods and compositions for the treatment of gastrointestinal disorders
EP2258358A3 (en)	2005-08-26	2011-09-07	Braincells, Inc.	Neurogenesis with acetylcholinesterase inhibitor
EP2275095A3 (en)	2005-08-26	2011-08-17	Braincells, Inc.	Neurogenesis by muscarinic receptor modulation
EP1940389A2 (en)	2005-10-21	2008-07-09	Braincells, Inc.	Modulation of neurogenesis by pde inhibition
AU2006308889A1 (en)	2005-10-31	2007-05-10	Braincells, Inc.	GABA receptor mediated modulation of neurogenesis
US20100216734A1 (en)	2006-03-08	2010-08-26	Braincells, Inc.	Modulation of neurogenesis by nootropic agents
JP2009536667A (ja)	2006-05-09	2009-10-15	ブレインセルス，インコーポレイティド	５ｈｔ受容体介在性の神経新生
EP2382975A3 (en)	2006-05-09	2012-02-29	Braincells, Inc.	Neurogenesis by modulating angiotensin
US8227603B2 (en) *	2006-08-01	2012-07-24	Cytokinetics, Inc.	Modulating skeletal muscle
PL2069352T3 (pl) *	2006-08-02	2014-03-31	Cytokinetics Inc	Określone cząstki chemiczne, kompozycje i sposoby
US8299248B2 (en) *	2006-08-02	2012-10-30	Cytokinetics, Incorporated	Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
AU2007292848A1 (en)	2006-09-08	2008-03-13	Braincells, Inc.	Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en)	2006-09-19	2010-07-22	Braincells, Inc.	Modulation of neurogenesis by ppar agents
EP2139478A4 (en) *	2007-03-30	2010-05-05	Cytokinetics Inc	CHEMICAL ENTITIES, COMPOSITIONS AND METHODS
MX354786B (es)	2007-06-04	2018-03-21	Synergy Pharmaceuticals Inc	Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
US8969514B2 (en)	2007-06-04	2015-03-03	Synergy Pharmaceuticals, Inc.	Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
GB0808947D0 (en) *	2008-05-16	2008-06-25	Shire Llc	Substituted quinazolines
GB0808967D0 (en) *	2008-05-16	2008-06-25	Shire Llc	Substitute quinazolines
GB0808968D0 (en) *	2008-05-16	2008-06-25	Shire Llc	Substitute quinazolines
GB0808952D0 (en) *	2008-05-16	2008-06-25	Shire Llc	Substituted quinazolines
ES2522968T3 (es)	2008-06-04	2014-11-19	Synergy Pharmaceuticals Inc.	Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
AU2009270833B2 (en)	2008-07-16	2015-02-19	Bausch Health Ireland Limited	Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
WO2010099217A1 (en)	2009-02-25	2010-09-02	Braincells, Inc.	Modulation of neurogenesis using d-cycloserine combinations
US9616097B2 (en)	2010-09-15	2017-04-11	Synergy Pharmaceuticals, Inc.	Formulations of guanylate cyclase C agonists and methods of use
DK2681236T3 (en)	2011-03-01	2018-04-16	Synergy Pharmaceuticals Inc	PROCEDURE FOR MANUFACTURING GUANYLATE CYCLASE-C-AGONISTS
BR112014000742A2 (pt)	2011-07-13	2016-08-23	Andrew A Wolff	terapia de combinação de als
WO2013106547A1 (en)	2012-01-10	2013-07-18	President And Fellows Of Harvard College	Beta-cell replication promoting compounds and methods of their use
WO2014131024A2 (en)	2013-02-25	2014-08-28	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase and their uses
AU2014235215A1 (en)	2013-03-15	2015-10-01	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase and their uses
AU2014235209B2 (en)	2013-03-15	2018-06-14	Bausch Health Ireland Limited	Guanylate cyclase receptor agonists combined with other drugs
BR112015030326A2 (pt)	2013-06-05	2017-08-29	Synergy Pharmaceuticals Inc	Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos
AU2014305843B2 (en)	2013-08-09	2019-08-29	Ardelyx, Inc.	Compounds and methods for inhibiting phosphate transport
EP4706758A3 (en)	2019-05-21	2026-05-06	Ardelyx, Inc.	Methods for inhibiting phosphate transport
WO2024149378A1 (zh) *	2023-01-13	2024-07-18	上海超阳药业有限公司	喹啉酮化合物和萘啶酮化合物及其用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3932407A (en) *	1973-11-19	1976-01-13	Bristol-Myers Company	Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones
NL7807507A (nl) *	1977-07-25	1979-01-29	Hoffmann La Roche	Tricyclische verbindingen.
US4490371A (en) *	1983-02-16	1984-12-25	Syntex (U.S.A.) Inc.	N,N-Disubstituted-(2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-B]quinazolinyl)oxyalkylamides
CA1254557A (en) *	1984-02-15	1989-05-23	Michael C. Venuti	(2-oxo-1,2,3,5-tetrahydroimidazo-(2,1-b) quinazolinyl) oxyalkylamides
US4668686A (en) *	1985-04-25	1987-05-26	Bristol-Myers Company	Imidazoquinoline antithrombrogenic cardiotonic agents
US4775674A (en) *	1986-05-23	1988-10-04	Bristol-Myers Company	Imidazoquinolinylether derivatives useful as phosphodiesterase and blood aggregation inhibitors
US4701459A (en) *	1986-07-08	1987-10-20	Bristol-Myers Company	7-amino-1,3-dihydro-2H-imidazo[4,5-b]quinolin 2-ones and method for inhibiting phosphodiesterase and blood platelet aggregation
US4943573A (en) *	1989-11-01	1990-07-24	Bristol-Myers Squibb Company	Imidazo[4,5-b]quinolinyloxyalkanoic acid amides with enhanced water solubility

1989
- 1989-11-01 US US07/430,228 patent/US4943573A/en not_active Expired - Fee Related
1990
- 1990-10-18 CA CA002027935A patent/CA2027935A1/en not_active Abandoned
- 1990-10-29 FI FI905326A patent/FI92697C/fi not_active IP Right Cessation
- 1990-10-29 NZ NZ235868A patent/NZ235868A/en unknown
- 1990-10-30 IL IL9616790A patent/IL96167A/en not_active IP Right Cessation
- 1990-10-30 NO NO904689A patent/NO175531C/no unknown
- 1990-10-30 YU YU205590A patent/YU205590A/sh unknown
- 1990-10-30 MY MYPI90001900A patent/MY105308A/en unknown
- 1990-10-30 JP JP2290987A patent/JPH03169880A/ja active Pending
- 1990-10-31 AU AU65679/90A patent/AU639033B2/en not_active Ceased
- 1990-10-31 CN CN90108762A patent/CN1025999C/zh not_active Expired - Fee Related
- 1990-10-31 ZA ZA908725A patent/ZA908725B/xx unknown
- 1990-10-31 RU SU904831618A patent/RU2041210C1/ru active
- 1990-10-31 OA OA59882A patent/OA09323A/xx unknown
- 1990-10-31 KR KR1019900017645A patent/KR910009705A/ko not_active Ceased
- 1990-10-31 PT PT95765A patent/PT95765A/pt not_active Application Discontinuation
- 1990-10-31 IE IE392390A patent/IE61579B1/en not_active IP Right Cessation
- 1990-10-31 EP EP19900120952 patent/EP0426180A3/en not_active Ceased
- 1990-11-01 EG EG65590A patent/EG19372A/xx active
- 1990-11-01 HU HU906977A patent/HU209305B/hu not_active IP Right Cessation

Also Published As

Publication number	Publication date
MY105308A (en)	1994-09-30
HU209305B (en)	1994-04-28
EP0426180A3 (en)	1992-01-08
IE61579B1 (en)	1994-11-16
HU906977D0 (en)	1991-05-28
JPH03169880A (ja)	1991-07-23
IE903923A1 (en)	1991-05-08
FI905326A0 (fi)	1990-10-29
YU205590A (sh)	1992-09-07
AU6567990A (en)	1991-05-23
FI92697B (fi)	1994-09-15
NZ235868A (en)	1993-12-23
CA2027935A1 (en)	1991-05-02
IL96167A (en)	1994-11-11
CN1051359A (zh)	1991-05-15
IL96167A0 (en)	1991-07-18
PT95765A (pt)	1991-09-13
RU2041210C1 (ru)	1995-08-09
ZA908725B (en)	1991-07-31
HUT56102A (en)	1991-07-29
NO904689D0 (no)	1990-10-30
AU639033B2 (en)	1993-07-15
FI92697C (fi)	1994-12-27
US4943573A (en)	1990-07-24
EG19372A (en)	1994-12-30
KR910009705A (ko)	1991-06-28
CN1025999C (zh)	1994-09-28
OA09323A (en)	1992-09-15
NO175531B (no)	1994-07-18
EP0426180A2 (en)	1991-05-08
NO175531C (no)	1994-10-26

Publication	Publication Date	Title
NO904689D0 (no)	1990-10-30	Fremgangsmaate til fremstilling av imidazo(4,5-b)-kinolinyloksyalkansyreamider.
NO167392C (no)	1991-10-30	Fremgangsmaate for fremstilling av imidazopyridiner.
NO890269D0 (no)	1989-01-20	Fremgangsmaate for fremstilling av 1,4-disubstituerte-piperidinyl-forbindelser.
NO900774L (no)	1990-08-22	Fremgangsmaate for fremstilling av polyamider.
BG95241A (bg)	1993-12-24	Метод за получаване на 2,9-дизаместени-4н-пиридо/1.2-а/ пиримидин-4-они
NO902003D0 (no)	1990-05-07	Fremgangsmaate for fremstilling av n-heteroaryl-4-quinolinaminer.
NO895067D0 (no)	1989-12-15	Fremgangsmaate til fremstilling av derivater av alfa, d-glukofuranose.
NO901554D0 (no)	1990-04-05	Fremgangsmaate for fremstilling av dinatrium-cefodizim.
NO904285D0 (no)	1990-10-02	Fremgangsmaate for fremstilling av substituerte karboksytetrahydroisokinoliner.
NO874302D0 (no)	1987-10-15	Fremgangsmaate for fremstilling av 4,5-dihydro- og 4,5,6,7-tetrahydro- pyrazolo (1,5-a)pyrimidiner.
NO905444D0 (no)	1990-12-18	Fremgangsmaate til fremstilling av oksazolderivater.
NO874888L (no)	1988-06-13	Fremgangsmaate til fremstilling av aminometyl-5,6,7,8-tetrahydronaftyloksyeddiksyrer.
NO901690D0 (no)	1990-04-17	Fremgangsmaate til fremstilling av substituerte azetidinylisotiazolpyridon-derivater.
ES518499A0 (es)	1983-10-01	Procedimiento para la preparacion de nuevas imidazo(1,2-a)pirimidinas.
NO903591D0 (no)	1990-08-15	Fremgangsmaate for fremstilling av pyrido(3,4-b)(1,4)benzoksazepiner samt anvendelse som medikamenter.
NO901067L (no)	1990-09-10	Fremgangsmaate for fremstilling av tiofener.
NO900969L (no)	1990-09-04	Fremgangsmaate for fremstilling av n-allymetatrifluormetylanilin.
NO882028L (no)	1988-11-30	Fremgangsmaate for fremstilling av cardiotone, tricykliskeimidazoloner.
FI874400A0 (fi)	1987-10-07	Foerfarande foer framstaellning av imidazo-4,5-b pyridin-2-on-derivat.
NO880409D0 (no)	1988-01-29	Fremgangsmaate for fremstilling av 14,15-substituerte lanosteroler.
NO904060L (no)	1991-03-20	Fremgangsmaate for fremstilling av substituerte dibenzofuraner.
NO874617D0 (no)	1987-11-05	Fremgangsmaate til fremstilling av 2,6-diamino-3-halogenobenzylpyridiner.
NO880338D0 (no)	1988-01-26	Fremgangsmaate for fremstilling av cycloalkan (1,2-c:4,3-c)dipyrazole.
NO880127L (no)	1988-07-15	Fremgangsmaate for fremstilling av (+-)-1,2-dihydro-3h-pyrrolo-(1,2-a)-pyrrol-1,7-dicarboxylater.
NO912673L (no)	1992-01-21	Fremgangsmaate for fremstilling av 7-amino-4,6-dinitrobenzofuroksan.